Immune globulin - Bio Products Laboratory
Alternative Names: Gammaplex; Subgam; Subgam-VFLatest Information Update: 13 Jan 2022
At a glance
- Originator Bio Products Laboratory
- Class Anti-infectives; Anti-inflammatories; Antibacterials; Antidementias; Antifibrotics; Antivirals; Eye disorder therapies; Immunoglobulins; Immunoproteins; Polyethylene glycols; Serum globulins; Skin disorder therapies; Vascular disorder therapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Immunodeficiency disorders
- Phase III Idiopathic thrombocytopenic purpura
Most Recent Events
- 28 Sep 2021 No development reported - Phase-III for Immunodeficiency disorders (In adolescents, In children, In adults) in USA (SC)
- 25 May 2017 Bio Products Laboratory completes a phase III trial in Immunodeficiency disorders (In children, In adolescents, In adults) in USA (SC) (NCT01884311)
- 07 Feb 2017 Registered for Idiopathic thrombocytopenic purpura (In adults) in USA (IV)